Alkyl Amines Chemicals Limited manufactures and supplies amines, amine derivatives, and other specialty chemicals in India and internationally. The company offers aliphatic amine products, such as methylamines, ethylamines, isopropylamines, n-propylamines, n-butylamines, ethylhexylamines, furfurylamines, and cyclohexylamines; and amine derivatives, including dimethylamine hydrochloride, diethylamine hydrochloride, triethylamine hydrochloride, 3-ethoxy propylamine, 3-(methylaminopropyl) amine, dimethylaminopropylamine, 3-(2-ethylhexyloxy) propylamine, n-methylbenzylamine, diisopropyl ethylamine, diethylhydroxylamine, diethyl toluamide, and diethylphenyl acetamide. It also provides specialty chemicals, such as acetonitrile; 1,8-diazabicyclo[5.4.0]undec-7-ene; diethylketone/3-pentanone; alchan 100; alchan 300; 2-aminoethoxy ethanol; 2-ethoxy ethylamine; dimethylpropyleneurea; tetramethyl ethylenediamine; monomethylamine; and tempo, free radical. The company serves pharmaceutical, agrochemical, water treatment, rubber chemical, and other industries. Alkyl Amines Chemicals Limited was incorporated in 1979 and is headquartered in Navi Mumbai, India.
Revenue projections:
Revenue projections for ALKYLAMINE With ALKYLAMINE's revenue expected to be lower than the previous year, investors may become cautious. Declining revenues often negatively impact the bottom line, reducing profitability and raising concerns among investors about the company's ability to maintain strong financial performance moving forward.
Financial Ratios:
currentRatio
2.570000
forwardPE
40.550583
debtToEquity
0.394000
earningsGrowth
0.196000
revenueGrowth
0.083000
grossMargins
0.454260
operatingMargins
0.145680
trailingEps
36.280000
forwardEps
0.000000
ALKYLAMINE's current ratio of 2.57 highlights the company's ability to easily cover its short-term debt using its available cash and assets. This indicates a strong liquidity position, ensuring ALKYLAMINE is unlikely to face difficulties in meeting immediate financial obligations.
Price projections:
Price projections for ALKYLAMINE ALKYLAMINE's price projections have been consistently revised upward, suggesting that analysts are becoming increasingly optimistic about the company's future. This trend reflects confidence in ALKYLAMINE's ability to achieve strong financial results.
ALKYLAMINE's stock price has moved above the upper limit of expected values, reflecting significant upward momentum. However, the limited potential for further rises indicates that the stock may face challenges in sustaining its current price.
Insider Transactions:
Insider Transactions for ALKYLAMINE
ALKYLAMINE saw 21 transactions in which shares were sold with market price at 2049.1714215959823.10 transactions to buy Alkyl Amines Chemicals Limited took place, with market price at 1784.875 per share.There is no clear trend from the insider transactions, providing limited insights into whether these actions reflect growth or decline.
Recommendation changes over time:
Recommendations trend for ALKYLAMINE
Analysts' sell bias for ALKYLAMINE suggests caution, but investors should base their decisions on a wide range of market indicators. This ensures a more comprehensive view of ALKYLAMINE's market potential and provides a better framework for making balanced investment decisions.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
An in-depth examination of the factors contributing to the U.S. dollar's multi-year...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.